Research summary, original research, 2026

Dose Evaluation of Medical Staff During Proximal Femur Fracture Surgery Using Fluoroscopy

Leite LMSA, Ribeiro LTR, Cruz ARPD, Barros VSM, Monte FA, Andrade THS, et al.. Journal of radiological protection : official journal of the Society for Radiological Protection. 2026

Read the original paper

In plain language

In 40 hip fracture operations in Brazil, surgeons' estimated annual eye lens doses were about 30% of the limit. Occasional hand exposure to the direct x-ray field accounted for most hand dose, so keeping hands out of the imaged field matters.

At a glance

Type of study
Original research, Dosimetry measurement study
Who was studied
Orthopedic surgeons
Size
n = 40 procedures
Where
Brazil
Summary based on
the abstract

What it found

  • Estimated annual effective doses for leading and auxiliary surgeons were about 1.3-1.5 mSv, roughly 7.5% of the annual limit, assuming 325 procedures per year.

    Key figures: 1.3-1.5 mSv; ~7.5% of annual limit (n= 325 procedures yr-1)

  • Estimated annual eye lens doses for both surgeons approached 30% of the current eye lens dose limit.

    Key figures: 4.7-5.8 mSv yr-1

  • Hp(10) measured on the thyroid shield correlated with Hp(3) at the glabella, suggesting it can serve as a preliminary indicator (within ±15%) of the need for dedicated eye lens monitoring.

    Key figures: ±15%; 15 mSv threshold

  • The glabella (forehead) was identified as the most appropriate eye lens dosimeter location; highest hand doses occurred in complex subtrochanteric fractures.

Limits to keep in mind

Single-hospital study of 40 procedures with annual doses extrapolated from an assumed workload of 325 procedures per year; only surgeons were monitored and details come from the abstract only.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.